Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. - Wikidata - wikimedia - TriplyDB

Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs.

Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs.

http://www.wikidata.org/entity/Q38336991

about

Antagonists show GTP-sensitive high-affinity binding to the sigma-1 receptor Breast cancer and social environment: getting by with a little help from our friends Re-Use of Established Drugs for Anti-Metastatic Indications Sympathetic nervous system regulation of the tumour microenvironment β-Adrenergic Receptor Signaling in Prostate Cancer Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic Approach Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes Galphas-coupled receptor signaling actively down-regulates alpha4beta1-integrin affinity: a possible mechanism for cell de-adhesion.Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration.Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D The sympathetic nervous system induces a metastatic switch in primary breast cancer.Tumor interactions with soluble factors and the nervous system.Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis Involvement of substance P and the NK-1 receptor in human pathology.The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.Impact of stress on cancer metastasis Effect of chronic restraint stress on human colorectal carcinoma growth in mice.The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival Beta-adrenergic signaling, a novel target for cancer therapy?Long-Term Use of Antihypertensive Agents and Risk of Breast Cancer: A Population-Based Case-Control Study.Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.Molecular pathways: beta-adrenergic signaling in cancer Efficiency of calcium phosphate composite nanoparticles in targeting Ehrlich carcinoma cells transplanted in mice.Beta-adrenergic blocking drugs in breast cancer: a perspective review The significance of substance P in physiological and malignant haematopoiesis Mechanisms of propranolol action in infantile hemangioma β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells.β-blockers: a novel class of antitumor agents.Nervous system regulation of the cancer genome.Neuroendocrine influences on cancer biology.Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: implications for intervention.Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid.β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent Prognostic significance of β2-adrenergic receptor expression in non-small cell lung cancer

P2860

Q24635201-7A3CD4C8-0FFB-4045-BE7C-21D7E90FED29 Q26745963-3E6F20C3-0C28-4FCC-890C-E7E7008B725A Q26771704-89EF3666-53C7-4FF3-A27A-1EA3000E1FD5 Q26795614-61236AFD-F697-40AA-991A-F1C9C2299950 Q28084943-B711B219-A8D6-434D-8C8B-B3B8535AD8BD Q28085005-DADA6A89-80E3-4130-9541-927E2D5DFFFE Q30962488-36E339FD-5292-46E1-B1DB-2E3C3378D9A2 Q33340853-AC5FE4DB-E88F-43B1-A57B-B22E39B5A19C Q33582909-9F102B9C-93AE-4C23-907B-54C71E110EC5 Q33887570-E926AAA4-92D9-4105-BABB-8013DBF69A8C Q33933654-3851A3F3-4997-4725-8BC6-C4962A3C0E94 Q34134468-A68DB2FE-AEB8-462A-A119-4B1565B90622 Q34142510-589A2393-9722-495F-A00F-DF30742B53F4 Q34285076-050A504E-8D3C-4998-BDBB-83A163D1D720 Q34413850-41648D67-1904-440B-AF42-DBC42CDE530B Q34475975-5950C8EB-F75B-41E2-8AC3-78AE934862E7 Q34569251-06ED5C66-CE5F-4A70-B2D5-C69CBF23B365 Q34667999-D449EE0A-A7E7-4BAB-AFDA-AA4617F8AFC0 Q35135129-287727DC-2F6E-4494-A0F1-F8654378345C Q35640094-F80F8450-302B-4023-89A9-7371D2B5127E Q35640106-5CA6C51E-3584-4B8D-8A0A-EFD3046BDE1F Q35756617-4279F7F4-E0EC-449C-8696-BDA0D7F85CA5 Q35773945-6B209849-95BB-4523-AA7B-6F643BA44282 Q35803280-3B0FEDAD-357E-4927-9E03-AA076205E564 Q35914285-E6D32AF7-F7A7-476E-9EAC-0B064F6DF7BF Q35949297-5589BCE7-A71F-4F84-877B-9926D29ACF58 Q36017182-2E3E0CC7-7441-417D-A9B1-F7D48D2889F4 Q36085996-67AE7229-7510-4B01-B1AD-2404270B3415 Q36213505-D5326039-05DB-4259-9F8C-F36A3B61C606 Q36443830-B7B9507E-5F82-4627-853F-86D4A71168AE Q36692566-BB7D40F6-FB96-463D-AF34-A656F77BDE02 Q36713229-DFC25FFE-4DE7-470A-A784-416B65292D22 Q36916872-70F2101A-A4A2-496A-A759-F6A93A3D3514 Q36953333-FEE51347-5B30-48D8-AB59-0461742CB9E6 Q37004651-DBF8D9A2-9D84-4127-B76C-28DF348EECE8 Q37087599-EB6503C0-99AF-43F3-A53E-156837E901C6 Q37292726-8E801EBF-1033-483A-85E3-B131EDFF67EA Q37300549-C955970B-957D-4190-B891-9B8DEF03A939 Q37404693-A5F49663-45D3-4103-A90F-F655792BCD03 Q37448247-6644B9DE-3E01-44C1-B741-645947FE869E

P2860

Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs.

http://www.wikidata.org/entity/Q38336991

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Induction of a metastatogenic ...... hibition by established drugs.

@en

type

label

Induction of a metastatogenic ...... hibition by established drugs.

@en

prefLabel

Induction of a metastatogenic ...... hibition by established drugs.

@en

P1433

Q38336991-5A9FA3E6-F3C5-4AD6-983F-523EDF67A9A5

P1476

Q38336991-1B46C0C5-881A-43B2-A90B-0C76BF78723B

P2093

Q38336991-52721A36-ED23-4202-BB2A-773EE260B0A0

Q38336991-8613AA3A-8A36-4361-AB62-27673F8F1FA0

Q38336991-97B00D49-5F12-46BA-8619-510CD1FC670F

Q38336991-CEA41DAA-0C86-4D51-AC7F-E497FA6D8178

Q38336991-EBA3442E-120A-44F3-8908-4A734A1BF618

Q38336991-EE1C9433-B644-45FD-9900-2310C52C9578

Q38336991-FB58B03A-9474-4323-B847-8EA583B149FE

P2860

Q38336991-4626E510-AE62-466D-B15F-DC0470D3C5C9

Q38336991-CC152523-6BB5-42F8-9B11-0B395EA908A6

Q38336991-D1E8AC41-96B7-4C7B-94AE-9B146922C2BC

P304

Q38336991-69B7D4D8-79B8-4236-B5C0-1FAB06E5AC79

P31

Q38336991-A9C81453-D7E9-48FC-9315-CD65140753D9

P356

Q38336991-90CBF419-3A33-430B-911A-FDC888A40127

P433

Q38336991-655E613D-F5B5-4C3A-B68D-DCC01B79E25D

P478

Q38336991-D4C2963E-FB99-4CD3-8921-8E60EEFF7390

P577

Q38336991-7D787030-647A-4A6B-A769-32088F9A195A

P5875

Q38336991-00B3493F-7EF6-4319-8303-5C9ED6B9C029

P698

Q38336991-E689FBD4-9BF7-4121-8187-E9FA0F63C802

P921

Q38336991-1707398A-2CF2-4EE0-9306-0AEDB8CEBB3D

P356

P1433

International Journal of Cancer

P1476

Induction of a metastatogenic ...... hibition by established drugs.

@en

P2093

Antje Lindecke

http://www.w3.org/2001/XMLSchema#string

Bernd Niggemann

http://www.w3.org/2001/XMLSchema#string

Christian Kaltschmidt

http://www.w3.org/2001/XMLSchema#string

Frank Entschladen

http://www.w3.org/2001/XMLSchema#string

Kerstin Lang

http://www.w3.org/2001/XMLSchema#string

Kurt S Zaenker

http://www.w3.org/2001/XMLSchema#string

Theodore L Drell

http://www.w3.org/2001/XMLSchema#string

P2860

Functional hierarchy of simultaneously expressed adhesion receptors: integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices

High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells.

Mesoprefrontal dopamine neurons and schizophrenia: role of developmental abnormalities.

P304

231-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.20410

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8361884

http://www.w3.org/2001/XMLSchema#string

P698

15352035

http://www.w3.org/2001/XMLSchema#string

P921

neurotransmitter